| abstract |
FIELD: pharmaceutics.SUBSTANCE: invention relates to the field of pharmaceutics, namely, to the use of the HAPLN1 protein or the gene encoding the HAPLN1 protein, or an effective agent to promote the expression or activation of the functions of the HAPLN1 protein or gene for the prevention or reduction of skin aging.EFFECT: use of the invention provides for the reduction or prevention of skin aging or signs of skin aging, such as wrinkles, by introducing the HAPLN1 protein or the gene encoding the HAPLN1 protein, or an effective agent for ensuring the expression or activation of the functions of the HAPLN1 protein or gene.5 cl, 12 dwg, 4 ex |